Alnylam Pharmace. buy Stifel Nicolaus
Summary
This prediction ended on 15.09.24 with a price of €240.20. With a performance of 32.41% the BUY prediction by Stifel_Nicolaus was a big success. Stifel_Nicolaus has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Stifel_Nicolaus has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Alnylam Pharmace. | 1.623% | 1.623% | 62.212% |
iShares Core DAX® | 1.867% | 3.031% | 27.591% |
iShares Nasdaq 100 | 1.427% | 5.634% | 18.496% |
iShares Nikkei 225® | 5.007% | 9.538% | 13.427% |
iShares S&P 500 | 1.241% | 4.277% | 12.130% |
Comments by Stifel_Nicolaus for this prediction
In the thread Alnylam Pharmace. diskutieren
In the thread Trading Alnylam Pharmace.
Current prediction by Stifel_Nicolaus for Alnylam Pharmace.
Alnylam Pharmace.
31.03.25
31.03.26
07.10.25
Stopped prediction by Stifel_Nicolaus for Alnylam Pharmace.
Alnylam Pharmace.
06.10.25
06.10.26
07.10.25
Alnylam Pharmace.
27.06.24
27.06.25
28.06.25